EN DE
Watch Fibromat (M) Berhad for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Fibromat (M) Berhad (0355) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of Fibromat (M) Berhad stock MYR 1.39, price MYR 0.73, upside +91.7%, quality 45 out of 100. Rating: strongly undervalued. Calculated from audited financials with 16 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Industrials MY

FM Fibromat (M) Berhad logo Thin data Nov 9, 2026

Fibromat (M) Berhad

0355 · KLSE
Cheap, value-trap risk

The stock costs 48% less than our calculation considers fair.

Fair value 1.39 MYR · Strongly undervalued
Solidly profitable · 13.8% net margin (TTM)
Low debt
Ranks above peers (9/13)
Revenue last quarter +33% vs. a year ago.
Quality 45/100
Expensive Growth (revenue 3y +33.3 %/yr in MYR)
Wide moat 66/100 · thin data
Negative free cash flow
Thin data
⚠ Thinly traded
Watch Fibromat (M) Berhad for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

0.9150 MYR 0.2626 MYR Fair Value 1.39 MYR May 2019 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 9, 2026.

How to read this chart

60‑month range 0.2626 MYR – 0.9150 MYR · fair‑value band 1.04 MYR – 1.73 MYR · the 0.7250 MYR price screens below the 1.39 MYR fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 9, 2026.

Follow Fibromat (M) Berhad in your weekly email

Every Wednesday you see whether Fibromat (M) Berhad is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Fibromat (M) Berhad, an investment holding company, engages in geotechnical solutions for erosion control, ground improvement, sediment control, and filtration and containment lining in Malaysia. It operates through three segments: Design and Installation Services, Trading, and Manufacturing.

Show moreShow less

It provides geotechnical solutions that include designing, manufacturing, and installation of geotechnical solutions using geosynthetics, erosion control, and biomass products; engineering techniques for drainage, filtration, separation, protection, and reinforcement; and erosion control blankets.

The company is also involved in the trading of geosynthetics and erosion control products; design and build services for erosion control and protection application; design, supply, and on-site installations: and manufacturing and sale of in-house products.

Its products are used in various applications, including slope stabilisation, ground improvement, riverbank and coastal protection, and soil erosion control. The company was founded in 1999 and is based in Batu Caves, Malaysia.

Stock analysis

Fibromat (M) Berhad (0355) currently trades at 0.7250 MYR, while our model-based Fair Value estimate is 1.39 MYR, implying the stock looks roughly 48% undervalued today.

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of 3.02 MYR per share, and 12 of the 16 models we run sit above the 0.7250 MYR price.

Bear case: the Dividend Discount group reads lowest at 0.1400 MYR, and 4 of the 16 models stay below the price. Data coverage for this calculation is low.

Scenario range: 1.04 MYR (bear) to 1.73 MYR (bull), the price of 0.7250 MYR sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 45/100 (below-average quality), in the Industrials sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Fibromat (M) Berhad reported revenue of 113M MYR in FY2025 versus 45.8M MYR in FY2021, a compound +25.5%/yr. Reported net income was 16.4M MYR in FY2025, compounding +29.9%/yr from FY2021.

Key figures

Market cap 180M MYR (≈ $44.4M) Micro · P/E ratio 9.1 · P/S ratio 1.33 · EPS (TTM) 0.0800 MYR · Dividend yield 1.1% · Net margin 13.8% · Return on equity 21.5% · Return on assets (EBIT) 14.1% (5-year average).

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 66 out of 100 (low confidence).

What moves the price

The share trades about 21% below its 52-week high and 14% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Industrials peers we cover trades at 3% fair-value upside, at 92%, 0355 screens cheaper than that median.

Fair Value models

Bear 1.04 MYR Fair Value 1.39 MYR Bull 1.73 MYR
Price 0.7250 MYR · Upside +91.7%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (0.0686 MYR per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
EPV 0.6300 MYR 0.7400 MYR 0.8300 MYR 71
EV/EBITDA 0.9800 MYR 1.33 MYR 1.68 MYR 67
Residual Income 0.4200 MYR 0.5800 MYR 1.08 MYR 67
All 16 models by family
Earnings-Based
Graham-Dodd 0.4500 MYR 3.13 MYR 4.39 MYR 59
Lynch FV 1.62 MYR 2.31 MYR 3.00 MYR 57
PEG = 1.0 1.62 MYR 2.31 MYR 3.00 MYR 53
EPV 0.6300 MYR 0.7400 MYR 0.8300 MYR 71
Dividend Discount
Gordon GGM 0.0800 MYR 0.1500 MYR 0.2200 MYR 62
DDM Multi-Stage 0.0800 MYR 0.1300 MYR 0.1600 MYR 62
Multiples
P/E Multiple 1.04 MYR 1.39 MYR 1.73 MYR 63
P/S Multiple 0.6900 MYR 0.9100 MYR 1.14 MYR 58
P/B Multiple 1.20 MYR 1.59 MYR 1.99 MYR 55
EV/EBIT 1.15 MYR 1.55 MYR 1.95 MYR 66
EV/EBITDA 0.9800 MYR 1.33 MYR 1.68 MYR 67
EV/Revenue 0.5100 MYR 0.7600 MYR 1.01 MYR 53
Asset-Based
NCAV (Graham) 0.1000 MYR 0.1600 MYR 0.2000 MYR 54
Economic Profit
Residual Income 0.4200 MYR 0.5800 MYR 1.08 MYR 67
ROIC Compounder 0.8600 MYR 1.32 MYR 1.61 MYR 67
Growth Earnings
Growth-Adj P/E 2.12 MYR 3.02 MYR 3.93 MYR 63

Open the full fair value analysis →

Quality Score breakdown

Overall quality 45/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 60
How much profit the company makes from its sales and capital
Quality Growth 58
Are margins and returns getting better?
Cashflow 0
Do the profits arrive as real cash?
Financial strength 80
Debt, balance sheet and risk of trouble
Investment 6
Does it invest with discipline instead of growing at any price?
Low Volatility 64
How calm the share price moves, does not count
Price momentum 40
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 40
Distance to the 52-week high, does not count
New shares 57
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 62/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+50.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+33.3%
What shareholders gained per year (last 5 years), in MYR (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip. Measured in MYR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+28.6%
Earnings growth per share plus dividend.
Earnings per share, growth per year+27.5%
Dividend (yield on the price)1.1%
Profit margin 2021 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.16% → 21%
2025 sits 68% above its own trend. The rate follows the median trend of the last 5 years, not that single year.

Watch 0355, get fair value alerts →

Compare Fibromat (M) Berhad with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Pollution & Treatment Controls · 85 stocks

Beats the industry median on 9/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 45 · Below median
Fair Value upside +91.7% · Top 25%
Profitability
Return on equity (12 months) 21.5% · Top 25%
Return on assets 11.4% · Top 25%
Net margin (12 months) 13.8% · Top 25%
Operating margin (12 months) 18.3% · Top 25%
Growth and dividend
Revenue growth (quarter YoY) 32.6% · Top 25%
Dividend yield (12 months) 1.1% · Below median
Balance sheet
Debt / equity 0.21× · Above median

Valuation Multiplesvs Pollution & Treatment Controls median · lower = cheaper

P/E (12 months) 9.1× · Cheapest 25%
P/B 2.05× · Pricier than median
P/S (12 months) 1.33× · Cheaper than median
EV/EBITDA 5.9× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 15
FUTURE (revenue growth)100 · sector 23
PAST (return on equity)86 · sector 20
HEALTH (low debt)90 · sector 95
DIVIDEND (yield)23 · sector 38

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Pollution & Treatment Controls stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
China Conch Venture Holdings 0586 HK$8.07 HK$24.21 +200% vs 0355
Jingjin Equipment Inc 603279 ¥13.33 ¥21.71 +63% vs 0355
Zurn Elkay Water Solutions Corporation ZWS $43.47 $48.24 +11% vs 0355
Mega Union Technology Inc 6944 608.00 TWD 663.94 TWD +9% vs 0355
Zhongyuan Environmental Protection Co 000544 ¥7.12 ¥7.36 +3% vs 0355
Fujian Longking Co 600388 ¥17.34 ¥12.37 −29% vs 0355
Veralto Corporation VLTO $117.09 $69.81 −40% vs 0355
Munters Group MTRS kr 128.95 kr 48.58 −62% vs 0355
GVS S.p.A GVS €5.84 €1.74 −70% vs 0355
CECO Environmental Corp CECO $43.71 $10.47 −76% vs 0355

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Fibromat (M) Berhad: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Fibromat (M) Berhad Fair Value". https://www.fairvalue-calculator.com/stock/0355

Frequently asked questions

Is Fibromat (M) Berhad (0355) overvalued or undervalued?
As of Nov 9, 2026, our model estimates a fair value of 1.39 MYR versus a price of 0.7250 MYR, about +92% upside (undervalued).
What is the fair value of 0355?
Our model-based fair value for Fibromat (M) Berhad is 1.39 MYR (as of Nov 9, 2026), built from audited fundamentals. The current price: 0.7250 MYR.
What is the quality score of 0355?
Fibromat (M) Berhad has a Quality Score of 45/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Fibromat (M) Berhad (0355)?
Our model-based price target is the fair value of 1.39 MYR (as of Nov 9, 2026) from 16 valuation models. Cautious scenario 1.04 MYR, optimistic scenario 1.73 MYR. It is a calculation from audited fundamentals, not an analyst target.
What is the Fibromat (M) Berhad stock forecast for 2026?
Our models put fair value at 1.39 MYR, about +92% upside versus a price of 0.7250 MYR (undervalued). Cautious scenario 1.04 MYR, optimistic scenario 1.73 MYR. The calculation is refreshed regularly with new filings.
What is the revenue of Fibromat (M) Berhad (0355)?
Fibromat (M) Berhad reported trailing-twelve-month revenue of about 135M MYR (latest available figure, as of Nov 9, 2026).
Does Fibromat (M) Berhad pay a dividend?
Fibromat (M) Berhad currently shows a dividend yield of 1.14% relative to its recent price (as of Nov 9, 2026).
How much is the dividend of Fibromat (M) Berhad (0355)?
Fibromat (M) Berhad has a dividend yield of 1.1%.
What is the intrinsic value of Fibromat (M) Berhad (0355)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Fibromat (M) Berhad it is 1.39 MYR per share (as of Nov 9, 2026), against a price of 0.7250 MYR. It is the blended result of 16 valuation models in 6 families (Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings).
Is Fibromat (M) Berhad stock overvalued or undervalued in 2026?
As of Nov 9, 2026, 0355 trades below its calculated fair value: price 0.7250 MYR, fair value 1.39 MYR, a gap of about +92% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 0355?
No. The price is what the market pays today (0.7250 MYR); the fair value is what the company's own numbers justify (1.39 MYR). For Fibromat (M) Berhad the two are 0.6650 MYR per share apart. That gap is exactly why we show both numbers side by side.
How much is Fibromat (M) Berhad worth?
The market values Fibromat (M) Berhad at about 180M MYR (market capitalisation, as of Nov 9, 2026). Per share that is 0.7250 MYR; our models calculate a fair value of 1.39 MYR per share.
What do the bullish and bearish scenarios say about 0355?
Our models span a range for Fibromat (M) Berhad: cautious scenario 1.04 MYR, base 1.39 MYR, optimistic 1.73 MYR per share (as of Nov 9, 2026, price 0.7250 MYR). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 0355?
Fibromat (M) Berhad trades at a price-to-earnings ratio of 9.1 (as of Nov 9, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 1.39 MYR is built from several models across several years. Other multiples: P/B 2.1, P/S 1.3, EV/EBITDA 5.9.
How solid is the balance sheet of Fibromat (M) Berhad (0355)?
Balance-sheet figures for Fibromat (M) Berhad (as of Nov 9, 2026): return on equity 21.5%, debt of 0.21 per unit of equity. They feed the Quality Score of 45/100, which measures business quality independently of the share price.
How far is 0355 from its 52-week high?
Fibromat (M) Berhad trades at 0.7250 MYR, about 21% below its 52-week high of 0.9150 MYR and 14% above the low of 0.6350 MYR (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of 1.39 MYR is for.
Which stocks are comparable to Fibromat (M) Berhad?
From the same area (Industrials) we also value Veralto Corporation, Zurn Elkay Water Solutions Corporation, Fujian Longking Co, Munters Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Fibromat (M) Berhad stock attractive at the current price?
The data as of Nov 9, 2026: price 0.7250 MYR, calculated fair value 1.39 MYR (+92%), Quality Score 45/100, from 16 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 0355 calculated?
We run Fibromat (M) Berhad through 16 models from 6 families: Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 1.39 MYR builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Fibromat (M) Berhad currently trades 48% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Fibromat (M) Berhad (0355)?
The closing price on Nov 6, 2026 was 0.7250 MYR. Our model-based fair value is 1.39 MYR, about +92% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Fibromat (M) Berhad right now?
The large discount to fair value meets weak quality (45/100). That raises the risk this is a value trap rather than a bargain. The price is below even our cautious bear case (1.04 MYR). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.

Key figures of Fibromat (M) Berhad

How large is the market capitalisation of Fibromat (M) Berhad (0355)?
The market capitalisation of Fibromat (M) Berhad is 180M MYR (≈ $44.4M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Fibromat (M) Berhad (0355)?
The price-to-sales ratio of Fibromat (M) Berhad is 1.33 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Fibromat (M) Berhad (0355)?
Earnings per share at Fibromat (M) Berhad are 0.0800 MYR (price ÷ EPS = P/E 9.1). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Fibromat (M) Berhad (0355)?
The dividend yield of Fibromat (M) Berhad is 1.1% (payout 10.4%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Fibromat (M) Berhad (0355)?
The net margin of Fibromat (M) Berhad is 13.8% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Fibromat (M) Berhad (0355)?
The return on equity (ROE) of Fibromat (M) Berhad is 21.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Fibromat (M) Berhad (0355)?
On an EBIT basis the return on assets of Fibromat (M) Berhad is 14.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Fibromat (M) Berhad (0355)?
The operating margin of Fibromat (M) Berhad is 18.3% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Fibromat (M) Berhad (0355)?
Revenue at Fibromat (M) Berhad is growing +32.6% versus a year earlier (3y avg +33.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Fibromat (M) Berhad (0355)?
Earnings per share at Fibromat (M) Berhad are growing −3.1% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Fibromat (M) Berhad (0355) generate?
The free cash flow of Fibromat (M) Berhad is −26.9M MYR (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Fibromat (M) Berhad (0355) carry?
The net debt of Fibromat (M) Berhad is 15.7M MYR (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Fibromat (M) Berhad in the live analysis

One click puts Fibromat (M) Berhad on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.